Skip to main content
NIH funding notice PA-16-177

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)

Closed on July 16, 2019.

Posted
April 8, 2016
Close date
July 16, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,094,486 in first-year total cost, median $207,516.

Most frequent study sections

  1. Cancer Molecular Pathobiology Study Section[CAMP]4
  2. Arthritis, Connective Tissue and Skin Study Section[ACTS]1
  3. Cancer Genetics Study Section[CG]1
  4. Macromolecular Structure and Function D Study Section[MSFD]1
  5. Mechanisms of Cancer Therapeutics - 1 Study Section[MCT1]1

Most frequent institutions

  1. BOSTON CHILDREN'S HOSPITAL1
  2. CORNELL UNIVERSITY1
  3. MASSACHUSETTS GENERAL HOSPITAL1
  4. RHODE ISLAND HOSPITAL1
  5. STANFORD UNIVERSITY1
Competing awards under PA-16-177 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Role of RNA methylation in chemoresistant cancer cells1R21CA220103-01A1VASUDEVAN, SHOBHAMASSACHUSETTS GENERAL HOSPITAL, MA$231,860CAMP
2020Cancer-associated alterations of the dihydrouridine landscape in kidney cancer1R21CA246118-01A1GILBERT, WENDY VICTORIAYALE UNIVERSITY, CT$227,120MGA
2019Role of m6A RNA methylation in Regulation of Translation in Human Glioblastoma1R21CA235415-01A1TAPINOS, NIKOLAOSRHODE ISLAND HOSPITAL, RI$225,983CG
2019NNMT regulation of m6A RNA modification in TNBC progression1R21CA239048-01CONZEN, SUZANNE DANIELAUNIVERSITY OF CHICAGO, IL$206,232MCT1
2018A-to-I microRNA Editing and Melanoma Metastasis1R21CA219958-01A1BARELI, MENASHEUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$208,800TPM
2018Dynamic mRNA m6A modification in oncogenic translation1R21CA227917-01QIAN, SHU-BINGCORNELL UNIVERSITY, NY$204,885CAMP
2018Uncovering the role of m6A in the melanocyte response to ultraviolet light1R21CA224391-01A1JAFFREY, SAMIE RZIPPIN, JONATHAN HALEWEILL MEDICAL COLL OF CORNELL UNIV, NY$184,331ACTS
2018HNRNPA2B1 as a reader of RNA methylation in breast cancer1R21CA219252-01A1KLINGE, CAROLYN M.SCHANER-TOOLEY, CHRISTINE EUNIVERSITY OF LOUISVILLE, KY$178,185CAMP
2017Role of m6A mRNA methylation in Neuroblastoma1R21CA219352-01GREGORY, RICHARD I.BOSTON CHILDREN'S HOSPITAL, MA$246,472CAMP
2017Computational tools for understanding chemically modified RNA structure and interactions1R21CA219847-01DAS, RHIJUSTANFORD UNIVERSITY, CA$180,618MSFD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-16-177: Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) | ScienceDex | ConductScience